Delivery Order SPE2DB25D3002-SPE2DB25FLRFZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,254.60 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on August 13, 2025, with completion targeted for August 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $26,128.50 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This non-set-aside, firm fixed-price delivery order was awarded on July 23, 2025, with an ultimate completion date of July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement fulfilling the Defense Health...
- The Defense Logistics Agency awarded a delivery order valued at $2,175.66 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (quantity: 8 units) on July 28, 2025, with an ultimate completion date of July 29, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a $7,797.87 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The contract is scheduled for completion by July 23, 2025, reflecting the expedited nature of this pharmaceutical procurement. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packages) with a ceiling value of $18,152.90. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through the open market. The order is scheduled for completion by August 15, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $15,976.54 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages). The contract, which is non-set-aside and competitively awarded, carries a firm fixed price and is scheduled for completion by July 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,307.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a $3,354.92 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a pharmaceutical supply delivery to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count) with a contract ceiling value of approximately $20.2K. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $13,515.86 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical supply to support federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- SPE2DB25D3002Indefinite Delivery Contract
- SPE2DB25D3002-SPE2DB25FLRFZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,010.72 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count package). This competitive award, with no set-aside designation, utilizes firm fixed pricing and calls for performance completion by August 15, 2025. AmerisourceBergen Drug Corp will fulfill this order from its Conshohocken, Pennsylvania facility, where the company maintains its corporate office operations. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion vehicle running through December 2026 that serves as the primary pharmaceutical support mechanism for military and federal healthcare systems globally. The contract enables the delivery of a comprehensive range of pharmaceuticals, medical supplies, and specialty medications across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare customers. AmerisourceBergen Drug Corp's competitively awarded contract portfolio demonstrates its established capability as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/14/25 |